Wave Life Sciences/$WVE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Wave Life Sciences
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Ticker
$WVE
Sector
Primary listing
Employees
288
Headquarters
Singapore, Singapore
Website
WVE Metrics
BasicAdvanced
$1.6B
-
-$0.84
-1.02
-
Price and volume
Market cap
$1.6B
Beta
-1.02
52-week high
$15.84
52-week low
$5.04
Average daily volume
1.7M
Financial strength
Current ratio
2.558
Quick ratio
2.404
Long term debt to equity
9.226
Total debt to equity
14.755
Profitability
EBITDA (TTM)
-139.916
Gross margin (TTM)
-80.88%
Net profit margin (TTM)
-138.24%
Operating margin (TTM)
-152.76%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
-38.90%
Return on equity (TTM)
-171.41%
Valuation
Price to revenue (TTM)
16.125
Price to book
10.91
Price to tangible book (TTM)
10.91
Price to free cash flow (TTM)
-7.57
Free cash flow yield (TTM)
-13.21%
Free cash flow per share (TTM)
-1.289
Growth
Revenue change (TTM)
-14.98%
Earnings per share change (TTM)
35.40%
3-year revenue growth (CAGR)
32.58%
10-year revenue growth (CAGR)
90.15%
3-year earnings per share growth (CAGR)
-25.68%
10-year earnings per share growth (CAGR)
-6.17%
What the Analysts think about WVE
Analyst ratings (Buy, Hold, Sell) for Wave Life Sciences stock.
WVE Financial Performance
Revenues and expenses
WVE Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Wave Life Sciences stock?
Wave Life Sciences (WVE) has a market cap of $1.6B as of August 18, 2025.
What is the P/E ratio for Wave Life Sciences stock?
The price to earnings (P/E) ratio for Wave Life Sciences (WVE) stock is 0 as of August 18, 2025.
Does Wave Life Sciences stock pay dividends?
No, Wave Life Sciences (WVE) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next Wave Life Sciences dividend payment date?
Wave Life Sciences (WVE) stock does not pay dividends to its shareholders.
What is the beta indicator for Wave Life Sciences?
Wave Life Sciences (WVE) has a beta rating of -1.02. This means that it has an inverse relation to market volatility.